RX CompoundedRxMonitor

Contact

Contact CompoundedRxMonitor

How to reach this publication, and which route to use.

Direct answer

General enquiries go to [email protected]. Entities named on this platform should use the right-to-respond route, which has a published process and service standard. Factual errors go to corrections. Every route is free and every submission is acknowledged within 2 business days.

Key findings

  • General: [email protected]
  • Named entities: use the right-to-respond route, which has a published process and timeframe.
  • Factual errors: use the corrections route; accepted corrections are logged with their date.
  • Acknowledgement within 2 business days on every route.
  • No route carries a fee.
Contact routes
General enquiries[email protected]
Named entity responseRight-to-respond process
Factual correctionsCorrections process
PostalPostal address to be published before launch
Acknowledgement2 business days
PublisherCompoundedRxMonitor
Evidence status License Verified routes published and operative
Verified 2026-07-23
Reviewer CompoundedRxMonitor Regulatory Desk
Snapshot 2026-07-23
Methodology v1.0

Which route to use

Contact routes and their service standards
If you are…UseTimeframe
An entity named on this platformRight to respond10 business days
Reporting a factual errorCorrections10 business days
A journalist or researcher[email protected]2 business days
Asking about methodologyEvidence policy first, then email2 business days
A provider seeking coverage or placementThere is no such routeCoverage cannot be purchased

Send a message

For anything that does not fit the routes above. If your entity is named on this platform, the right-to-respond route is faster and carries a published service standard.

Or email [email protected] with the same information.

What happens next. General enquiries are acknowledged within 2 business days. If your message concerns a record about a named entity it will be redirected to the right-to-respond process, which carries a published service standard.

What this means

  • Every route is free and every submission is acknowledged.
  • Named entities have a published process with a stated timeframe.
  • Accepted corrections are logged in the record's update history with their date.

What this does not mean

  • That coverage or placement can be requested, purchased, or negotiated.
  • That an accurate record will be removed on request.
  • That this platform provides legal or medical advice.
Independence statement. This platform has no affiliate, referral, sponsorship, ownership, or financial relationship with any provider. Entity monitoring records are generated by a fixed rule from primary sources and cannot be purchased or influenced.
Limitations of this record.
  • Service standards are targets, not guarantees.
  • This publication cannot give legal or medical advice, and will not attempt to.
  • Requests for coverage, placement, or listing are declined — there is no route for them.
  • Postal address and form endpoint are outstanding and must be published before launch.
Where the detail lives. The eight items to establish before paying any programme are listed on the patient safety page.

Section hub: Governance · Methodology · Status definitions · Right to respond

Frequently asked questions

How do I contact the publication?

Email [email protected], or use the form on this page.

My company is named here. What should I use?

The right-to-respond route. It has a published process and service standard.

Can I request coverage or a listing?

No. Coverage cannot be purchased, requested, or negotiated on this platform.

How fast will I get a reply?

Acknowledgement within 2 business days; substantive reply within 10 business days.

Sources

Update history

Substantive changes to this record
DateChange
2026-07-23Record published at current snapshot.

Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.